Canada markets close in 1 hour 16 minutes

CohBar, Inc. (CWBR)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Add to watchlist
0.24050.0000 (0.00%)
As of 01:19PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.2405
Open0.2405
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2405 - 0.2405
52 Week Range0.0010 - 3.5900
Volume50
Avg. Volume981
Market Cap699,116
Beta (5Y Monthly)1.43
PE Ratio (TTM)N/A
EPS (TTM)-4.3700
Earnings DateJul 17, 2024 - Jul 20, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)

    MENLO PARK, Calif., November 27, 2023--On November 20, 2023, CohBar, Inc. (the "Company") was notified by the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") of its determination pursuant to Nasdaq Listing Rule 5101 that, based upon the Staff’s belief that the Company is a "public shell," and that the continued listing of the Company’s securities is no longer warranted, and the Company’s non-compliance with certain board and committee composition listing

  • GlobeNewswire

    CohBar Reports Second Quarter 2023 Financial Results

    MENLO PARK, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) today reported its financial results and highlights for the second quarter ended June 30, 2023. Second Quarter 2023 Summary and Financial Results Entered into Definitive Merger Agreement with Morphogenesis: In May 2023, CohBar announced that the company entered into a definitive merger agreement with a privately held biotechnology company, Morphogenesis, Inc. (“Morphogenesis”), for an all-stock transaction to advan